| OUTSOURCING REVIEW |
Jim Miller
Moving global manufacturing operations may be more complicated than it appears.
/ read more /
| API SYNTHESIS & MANUFACTURING |
Cynthia A. Challener
Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.
/ read more /
| TROUBLESHOOTING |
Richard Denk
The new ISPE Containment Manual is a summary of the process involved in the manufacture of highly active or highly hazardous pharmaceutical substances.
/ read more /
| ASK THE EXPERT |
Siegfried Schmitt
Siegfried Schmitt, PhD, Principal Consultant at PAREXEL, discusses how to mitigate risk in a global regulatory environment.
/ read more /
| FEATURES |
Oskar Gold
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
/ read more /
Michael Pfeiffer, PhD
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
/ read more /
Philip Lienbacher, Manfred Karner
By working together and taking a QA-based approach, manufacturers and suppliers can reduce raw material testing requirements.
/ read more /
Susan J. Schniepp
A robust quality agreement and good communication scheme can help avoid and alleviate regulatory concerns.
/ read more /
Staffan Widengren
Many pharmaceutical manufacturers were late in involving contract partners in serialization efforts. Are you ready, and are you working with the right partner?
/ read more /
Monica McDonnell
Having an effective and granular data management process in place will enable companies to meet the requirements of IDMP as well as help usher in a new age of digital-based identification, in which organizations can easily share data across borders.
/ read more /
|